Perrigo Revenue 2006-2020 | PRGO
Perrigo annual/quarterly revenue history and growth rate from 2006 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Perrigo revenue for the quarter ending June 30, 2020 was $1.219B, a 6.1% increase year-over-year.
- Perrigo revenue for the twelve months ending June 30, 2020 was $5.074B, a 9.08% increase year-over-year.
- Perrigo annual revenue for 2019 was $4.837B, a 2.23% increase from 2018.
- Perrigo annual revenue for 2018 was $4.732B, a 4.34% decline from 2017.
- Perrigo annual revenue for 2017 was $4.946B, a 6.33% decline from 2016.
| Perrigo Annual Revenue (Millions of US $) |
|
|---|---|
| 2019 | $4,837 |
| 2018 | $4,732 |
| 2017 | $4,946 |
| 2016 | $5,281 |
| 2015 | $2,632 |
| 2015 | $4,227 |
| 2014 | $3,914 |
| 2013 | $3,540 |
| 2012 | $3,173 |
| 2011 | $2,755 |
| 2010 | $2,268 |
| 2009 | $2,006 |
| 2008 | $1,730 |
| 2007 | $1,368 |
| 2006 | $1,367 |
| 2005 | $1,024 |
| Perrigo Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2020-06-30 | $1,219 |
| 2020-03-31 | $1,341 |
| 2019-12-31 | $1,323 |
| 2019-09-30 | $1,191 |
| 2019-06-30 | $1,149 |
| 2019-03-31 | $1,175 |
| 2018-12-31 | $1,195 |
| 2018-09-30 | $1,133 |
| 2018-06-30 | $1,186 |
| 2018-03-31 | $1,217 |
| 2017-12-31 | $1,283 |
| 2017-09-30 | $1,231 |
| 2017-06-30 | $1,238 |
| 2017-03-31 | $1,194 |
| 2016-12-31 | $1,331 |
| 2016-09-30 | $1,262 |
| 2016-06-30 | $1,341 |
| 2016-03-31 | $1,347 |
| 2015-12-31 | $-1,023 |
| 2015-09-30 | $1,273 |
| 2015-06-30 | |
| 2015-03-31 | $967 |
| 2014-12-31 | $1,072 |
| 2014-09-30 | $952 |
| 2014-06-30 | |
| 2014-03-31 | $1,004 |
| 2013-12-31 | $979 |
| 2013-09-30 | $933 |
| 2013-06-30 | |
| 2013-03-31 | $920 |
| 2012-12-31 | $883 |
| 2012-09-30 | $770 |
| 2012-06-30 | |
| 2012-03-31 | $778 |
| 2011-12-31 | $838 |
| 2011-09-30 | $725 |
| 2011-06-30 | |
| 2011-03-31 | $692 |
| 2010-12-31 | $718 |
| 2010-09-30 | $641 |
| 2010-06-30 | |
| 2010-03-31 | $538 |
| 2009-12-31 | $582 |
| 2009-09-30 | $528 |
| 2009-06-30 | |
| 2009-03-31 | $506 |
| 2008-12-31 | $537 |
| 2008-09-30 | $456 |
| 2008-06-30 | |
| 2008-03-31 | $481 |
| 2007-12-31 | $435 |
| 2007-09-30 | $383 |
| 2007-06-30 | |
| 2007-03-31 | $362 |
| 2006-12-31 | $371 |
| 2006-09-30 | $340 |
| 2006-06-30 | |
| 2006-03-31 | $332 |
| 2005-12-31 | |
| 2005-09-30 | $320 |
| 2005-06-30 | |
| 2005-03-31 | $220 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $7.183B | $4.837B |
| Perrigo Company plc develops, manufactures and distributes healthcare products. The company operates primarily in four segments: Consumer Healthcare, Nutritionals, Rx Pharmaceutical and Active Pharmaceutical Ingredients. It also provides animal health products. The company operates primarily in the United States, the United Kingdom, Mexico, Israel, Australia, Canada, China and Latin America. Perrigo Company plc formerly known as Perrigo Company is headquartered in Ireland. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $179.001B | 33.59 |
| Medtronic (MDT) | Ireland | $135.860B | 22.07 |
| Stryker (SYK) | United States | $71.577B | 27.76 |
| Boston Scientific (BSX) | United States | $56.869B | 32.85 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.267B | 0.00 |
| Baxter (BAX) | United States | $42.847B | 26.20 |
| Terumo (TRUMY) | Japan | $30.297B | 38.73 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $28.806B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $28.554B | 23.70 |
| ResMed (RMD) | United States | $25.680B | 37.29 |
| Sunny Optical Technology (SNPTF) | China | $20.071B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $18.382B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $15.129B | 68.43 |
| Insulet (PODD) | United States | $13.561B | 573.78 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $12.315B | 0.00 |
| DiaSorin S.p.A (DSRLF) | Italy | $11.312B | 0.00 |
| Quidel (QDEL) | United States | $10.461B | 55.42 |
| GN STORE NORD (GNNDY) | Denmark | $8.157B | 41.58 |
| William Demant Holdings (WILYY) | Denmark | $7.457B | 0.00 |
| Canopy Growth (CGC) | Canada | $6.424B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $6.414B | 15.92 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $4.422B | 0.00 |
| Haemonetics (HAE) | United States | $4.266B | 28.43 |
| Neogen (NEOG) | United States | $4.124B | 68.91 |
| ICU Medical (ICUI) | United States | $3.954B | 30.17 |
| Envista Holdings (NVST) | United States | $3.841B | 26.20 |
| Abcam (ABCZY) | $3.703B | 0.00 | |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.368B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.893B | 449.63 |
| Agios Pharmaceuticals (AGIO) | United States | $2.839B | 0.00 |
| NuVasive (NUVA) | United States | $2.649B | 36.91 |
| TG Therapeutics (TGTX) | United States | $2.581B | 0.00 |
| DFB Healthcare Acquisitions (AHCO) | United States | $2.053B | 187.31 |
| AtriCure (ATRC) | United States | $1.816B | 0.00 |
| MacroGenics (MGNX) | United States | $1.504B | 0.00 |
| NanoString Technologies (NSTG) | United States | $1.495B | 0.00 |
| Aphria (APHA) | Canada | $1.338B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $1.175B | 0.00 |
| Cerus (CERS) | United States | $1.172B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.133B | 0.00 |
| Quanterix (QTRX) | United States | $1.066B | 0.00 |
| InMode (INMD) | Israel | $1.023B | 25.80 |
| Owens & Minor (OMI) | United States | $1.014B | 22.71 |
| OraSure Technologies (OSUR) | United States | $0.962B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.904B | 12.53 |
| PetIQ (PETQ) | United States | $0.839B | 24.24 |
| Meridian Bioscience (VIVO) | United States | $0.784B | 18.10 |
| Phibro Animal Health (PAHC) | United States | $0.773B | 15.42 |
| Vapotherm (VAPO) | United States | $0.755B | 0.00 |
| Omeros (OMER) | United States | $0.719B | 0.00 |
| Surmodics (SRDX) | United States | $0.645B | 70.73 |
| BioLife Solutions (BLFS) | United States | $0.604B | 314.50 |
| Zynex (ZYXI) | United States | $0.588B | 51.36 |
| LeMaitre Vascular (LMAT) | United States | $0.586B | 35.79 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.585B | 82.64 |
| VAREX IMAGING (VREX) | United States | $0.502B | 21.75 |
| Viemed Healthcare (VMD) | United States | $0.415B | 14.82 |
| HEXO (HEXO) | $0.376B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.374B | 0.00 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.312B | 0.00 |
| Utah Medical Products (UTMD) | $0.309B | 26.53 | |
| InfuSystems Holdings (INFU) | United States | $0.274B | 52.50 |
| Organigram Holdings (OGI) | Canada | $0.244B | 0.00 |
| Exagen (XGN) | United States | $0.209B | 0.00 |
| Female Health (VERU) | United States | $0.186B | 0.00 |
| Chimerix (CMRX) | United States | $0.182B | 0.00 |
| Bovie Medical (APYX) | United States | $0.176B | 0.00 |
| Fonar (FONR) | United States | $0.168B | 14.85 |
| Surface Oncology (SURF) | United States | $0.166B | 0.00 |
| Wound Management Technologies (SMTI) | United States | $0.162B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.134B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.125B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.122B | 0.00 |
| Evolus (EOLS) | United States | $0.122B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.115B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.103B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.086B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.082B | 0.00 |
| Brainsway (BWAY) | Israel | $0.074B | 0.00 |
| United-Guardian (UG) | United States | $0.073B | 16.36 |
| Nephros (NEPH) | United States | $0.070B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.051B | 0.00 |
| ImmuCell (ICCC) | United States | $0.040B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.034B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.033B | 0.00 |
| FSD PHARMA INC (HUGE) | Canada | $0.025B | 0.00 |
| NF Energy Saving (BIMI) | China | $0.020B | 0.00 |
| Myomo (MYO) | United States | $0.014B | 0.00 |
| Conatus Pharmaceuticals (HSTO) | United States | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Senestech (SNES) | United States | $0.006B | 0.00 |
